EMA401, An Orally Administered Highly Selective Angiotensin II Type 2 Receptor Antagonist, as a Novel Treatment for Postherpetic Neuralgia: A Randomised, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial
Lancet 383:1637-1647, Rice, A.C.,et al, 2014
Postherpetic Neuralgia
NEJM 371:1526-1533, Johnson, R.W.,et al, 2014
Spinal MR Findings in Continuous Epidural Analgesia Without Infection
AJNR 26:991-995,987, Ikushima,I.,et al, 2005
Treatment of Herpes Zoster and Postherpetic Neuralgia
BMJ 326:748-750, Johnson,R.W. &Dworkin,R.H., 2003
Intrathecal Methylprednisolone for Intractable Postherpetic Neuralgia
NEJM 343:1514-1519,1563, Kotani,N.,et al, 2000
Post-Herpes Zoster Neuralgia:Response to Vitamin E Therapy
Arch Dermatol 108:855, Ayres,S.Jr.,et al, 1973
Relief of Postherpetic Neuralgia with Psychotropic Drugs
J Neurosurg 39:235-239, Taub,A.,et al, 1973